SEARCH ARTICLES



LATEST ARTICLES

Table of Contents

2020 Month : May Volume : 9 Issue : 18 Page : 1475-1479

Study on the Clinico-Haematological Profile of Patients of Non-Transfusion Dependent Thalassemia (NTDT) Attending Thalassemia Clinic at a Tertiary Care Hospital.

Indrani Das1, Ananya Sengupta2, Abhishek Chakrabarti3, Arindam Kargupta4, Krishnendu Roy5

1Department of General Medicine, Medical College and Hospital, Kolkata, West Bengal, India. 2Department of General Medicine, Medical College and Hospital, Kolkata, West Bengal, India. 3Department of General Medicine, Medical College and Hospital, Kolkata, West Bengal, India. 4Department of General Medicine, Medical College and Hospital, Kolkata, West Bengal, India. 5Department of General Medicine, Medical College and Hospital, Kolkata, West Bengal, India.

References :

1

Musallam KM, Rivella S, Vichinsky E, et al. Non-transfusion-dependent thalassemias. Haematologica 2013;98(6):833-44.        

CrossRef | Google Scholar | PubMed
2

Weatherall DJ. The definition and epidemiology of non-transfusion-dependent thalassemia. Blood Rev 2012;(26 Suppl 1):S3-6.   

CrossRef | Google Scholar | PubMed
3

Colah RB. Control Strategies for Hemoglobinopathies in India. Scientist F- Dept Director (SG), F Deputy (SG), National Institute of Immunohaematology, Parel, Mumbai.          

4

Musallam KM, Rivella S, Vichinsky E, et al. Non-transfusion-dependent thalassemias. Haematologica 2013;98(6):833-44.                   

Google Scholar | PubMed
5

Gardenghi S, Grady RW, Rivella S. Anemia, ineffective erythropoiesis and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in beta-thalassemia. Hematol Oncol Clin North Am 2010;24(6):1089-107.                      

CrossRef | Google Scholar | PubMed
6

Musallam KM, Cappellini MD, Wood JC, et al. Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia. Haematologica 2011;96(11):1605-12.               

CrossRef | Google Scholar | PubMed
7

Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood 2002;99(1):36-43.                

CrossRef | Google Scholar | PubMed
8

Musallam KM, Cappellini MD, Daar S, et al. Serum ferritin levels and morbidity in β-thalassemia intermedia: a 10-year cohort study. Blood 2012;120(21):1021.      

Google Scholar |
9

Olivieri NF, De Silva S, Premawardena A, et al. Iron overload and iron-chelating therapy in hemoglobin E-beta thalassemia. J Pediatr Hematol Oncol 2000;22(6):593-7.

CrossRef | Google Scholar | PubMed
10

Taher AT, Porter J, Viprakasit V, et al. Deferasirox reduces iron overload significantly in non-transfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study. Blood 2012;120(5):970-7.         

CrossRef | Google Scholar | PubMed